Studies cast doubt on migraine-relief surgery

07/1/2014 | HealthDay News

Two studies on migraine trigger deactivation surgery had flawed study methods, and the surgery is expensive and risky, according to an analysis presented at the American Headache Society's annual meeting. Some patients experience lingering itchiness and numbness after the surgery, researchers said. The treatment should be studied further and appears to work for some patients, but it should not be marketed as a cure, the team said.

View Full Article in:

HealthDay News

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Market Access Manager Electrophysiology HEOR (AEP) - 15000003NZ
Abbott
Menlo Park, CA
Sales Manager, Employer Programs
PartnerRe Health